NewsRx

Search our medical news database

Complementary and Alternative Medicine

Cancer Specialist Calls for Proper Clinical Trials

Published in Cancer Weekly, October 31st, 2000

The conflict between conventional and complementary cancer treatment may be resolved if only both sides could find a way of organizing properly funded, high quality clinical trials, attendees at a cancer conference were told.

Now a leading U.K. cancer specialist, Prof. John Smyth, is considering hosting a meeting where conventional and complementary practitioners can get together and discuss how to conduct the research. He told a news briefing at the 2nd European Breast Cancer Conference in Brussels, Belgium: "It is a priority that we get together and discuss this. Good trials are the intelligent way forward, but this type of research is really difficult. It isn't...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook